Business & Industry

CSPC Pharmaceutical and AstraZeneca form Biologics Joint Venture

Yuvraj — Thu, 06 Aug 2026 12:04:34 +0000

CSPC Pharmaceutical and AstraZeneca have signed a joint venture contract to establish a new-generation production facility in Shijiazhuang, China. The collaboration focuses on the manufacturing and global supply of mutually agreed biologics drug substances, with capital contributions structured at a 51:49 equity ratio in favor of CSPC Pharmaceutical. The agreement remains subject to customary closing […]

The post CSPC Pharmaceutical and AstraZeneca form Biologics Joint Venture first appeared on World Pharma Today.

Bristol Myers Squibb Expands Strategic AI Partnership with Schrödinger

Yuvraj — Thu, 06 Aug 2026 11:56:27 +0000

Bristol Myers Squibb has expanded its ongoing strategic partnership with Schrödinger through a new agreement to deploy the agentic AI co-scientist platform, Bunsen, across its research operations. Building upon an established collaboration in which Bristol Myers Squibb already utilizes Schrödinger computational tools, this enterprise-wide integration is designed to help scientific teams evaluate drug discovery AI […]

The post Bristol Myers Squibb Expands Strategic AI Partnership with Schrödinger first appeared on World Pharma Today.

CDSCO to Introduce Integrated Drug Regulatory Platform in 18 Months

Yuvraj — Sat, 01 Aug 2026 08:52:49 +0000

The Central Drugs Standard Control Organisation (CDSCO) has announced plans to launch the first phase of a comprehensive end-to-end digital drug regulatory platform within the next 18 months. Designed as a single-window interface for the Indian pharmaceutical industry, the platform aims to streamline regulatory processes, enhance operational efficiency, increase transparency, and simplify compliance oversight across […]

The post CDSCO to Introduce Integrated Drug Regulatory Platform in 18 Months first appeared on World Pharma Today.

WHO Introduces Global Regulatory Framework for Decarbonizing Pharmaceuticals

Yuvraj — Fri, 31 Jul 2026 11:43:16 +0000

The World Health Organization (WHO) has officially launched the first global framework intended to assist medicines regulators in advancing the development of greener pharmaceuticals while maintaining the highest standards of safety, quality, and efficacy. The document, titled “Towards a greener pharmaceuticals’ regulatory highway: a framework for regulators as enablers of decarbonization,” outlines how regulatory authorities […]

The post WHO Introduces Global Regulatory Framework for Decarbonizing Pharmaceuticals first appeared on World Pharma Today.

Merck Signs Voluntary Licensing Deals for Oral HIV Pill

Yuvraj — Fri, 24 Jul 2026 12:05:28 +0000

Merck has entered into seven voluntary licensing agreements with generic manufacturers to produce and distribute lower-cost versions of alimatravir, its experimental once-monthly oral HIV pill. The royalty-free agreements will cover both public and private sectors across 129 low- and lower-middle-income countries, where a substantial majority of new HIV diagnoses globally occur. Although alimatravir remains in […]

The post Merck Signs Voluntary Licensing Deals for Oral HIV Pill first appeared on World Pharma Today.

Trump Proposes Generic Drug Tariffs to Drive Reshoring Effort

Yuvraj — Thu, 23 Jul 2026 12:44:08 +0000

President Donald Trump announced plans to implement massive generic drug tariffs starting at 100% in August 2028, scaling up to 200% in August 2029, in an effort to incentivize the pharmaceutical industry to move production to the United States. The proposed policy imposes a timeline that extends beyond Trump’s current term in office. Describing the […]

The post Trump Proposes Generic Drug Tariffs to Drive Reshoring Effort first appeared on World Pharma Today.

Bristol Myers Squibb Deploys Advanced Computing Cluster for Research

Yuvraj — Tue, 21 Jul 2026 07:05:58 +0000

Pharmaceutical giant Bristol Myers Squibb has announced the deployment of its second NVIDIA DGX SuperPOD, an advanced computing cluster designed to accelerate the drug discovery pipeline. This new infrastructure, which utilizes the Vera Rubin architecture, represents a significant commitment to integrating high-performance computing into the core of biological research. The company is positioning this move […]

The post Bristol Myers Squibb Deploys Advanced Computing Cluster for Research first appeared on World Pharma Today.

Australia Reviews PBS Pricing Framework Amid Industry Dispute Over Benchmarks

Yuvraj — Fri, 17 Jul 2026 11:30:51 +0000

The Australian government is currently navigating a significant period of reassessment regarding its national drug reimbursement model, as tensions between global pharmaceutical manufacturers and health regulators reach a critical juncture. At the center of this dispute is the Pharmaceutical Benefits Scheme (PBS), a system that has long served as the primary mechanism for ensuring affordable […]

The post Australia Reviews PBS Pricing Framework Amid Industry Dispute Over Benchmarks first appeared on World Pharma Today.

SK Telecom and SK Biopharmaceuticals Identify Lead Compounds for Cancer Treatment via AI

Yuvraj — Wed, 15 Jul 2026 13:29:18 +0000

SK Telecom and SK Biopharmaceuticals have announced the successful identification of early lead compounds designed for the development of targeted therapies for intractable cancers. By leveraging AI Drug Discovery, the joint research team discovered two specific substances capable of binding to ROR1, a protein found on the surface of malignant cells. A major highlight of […]

The post SK Telecom and SK Biopharmaceuticals Identify Lead Compounds for Cancer Treatment via AI first appeared on World Pharma Today.

Senate Investigates Foreign Control and Ownership within the Pharmaceutical Sector

Yuvraj — Tue, 14 Jul 2026 13:41:05 +0000

The Senate Special Committee on Aging is preparing to conduct a hearing titled “Behind The Label: Focusing On Foreign Ownership And Control In America’s Drug Supply Chain.” Scheduled for Wednesday, July 15, the session arrives as the industry faces significant pressure from impending tariffs on imported medications. Senator Rick Scott, serving as the committee chair, […]

The post Senate Investigates Foreign Control and Ownership within the Pharmaceutical Sector first appeared on World Pharma Today.